Investseekers looks at Novo's Oral Wegovy launch in France and beyond
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
Recap by typeshit. Post by Investseekers on X.
Investseekers shares notes on the upcoming French rollout of the Wegovy pill and where Novo Nordisk might launch it next in Europe.
Recap by typeshit. Post by Investseekers on X.
ABC News' chief medical correspondent walks through the latest Novo Nordisk GLP-1 medication and what sets it apart from drugs already on the market.
A short social clip runs through the daily checklist of a GLP-1 routine: injections, water, protein and keeping tabs on progress.
Kumar says month one is less about big drops on the scale and more about setting up habits that help the medication work over time.
12:50
Alex Wallace, who bills himself as a peptide expert, gives his response to what Dr. Mike has said about peptides. Details beyond the title are thin.
At the Cardiometabolic Health Congress, the UAB professor asked whether maximal weight loss is optimal and flagged that most non-diabetic patients quit GLP-1s within two years.
An older explainer sorting the weight loss market into approved medications, telehealth compounded drugs, online gray market peptides and supplements.
Loading…